Discounted for Persistent Weakness, Not Opportunity
Bayer trades at a discount for persistent operational weakness, not hidden value. A 2.3% ROIC and 7.1% margin keep pressure on the stock. Regulatory and pricing headwinds hit harder than for peers. Cheap for a reason—this isn’t a turnaround yet.
Published by AssetNext · 2026-06-05
| Date | Signal | Peer score | Drawdown | 21d vs sector |
|---|---|---|---|---|
| 2026-06-03 | Profile and price weak | 60 | -29.4% | -29.5% |
| 2026-05-28 | Profile and price weak | 60 | -23.0% | -26.8% |
| 2026-05-22 | Profile and price weak | 60 | -21.7% | -14.9% |
Break down BAYN.DE's structural position across all peer dimensions with the interactive app.